| Ab | Antibodies |
| ADC | Antibody-Targeted Cytotoxic Drug Conjugates |
| ADCC | Antibody-Dependent Cellular Cytotoxicity |
| ADCP | Antibody-Dependent Cellular Phagocytosis |
| ALL | Acute Lymphoblastic Leukemia |
| AML | Acute Myeloid Leukemia |
| BCR | B-cell Receptor |
| BL | Burkitt Lymphoma |
| BSA | Bovine Serum Albumin |
| CAR | Chimeric Antigen Receptor |
| CDC | Complement-Dependent Cytotoxicity |
| DLBCL | Diffuse Large B-cell Lymphoma |
| EC | European Commission |
| EMA | European Medicines Agency |
| EPR | Enhanced Permeability and Retention |
| ESF | European Science Foundation |
| Fab | Antigen-Binding Fragment |
| FDA | Food and Drug Administration |
| HSA | Human Serum Albumin |
| ICI | Immune Checkpoint inhibitor |
| mAbs | Monoclonal Antibodies |
| MPS | Mononuclear Phagocyte System |
| MRI | Magnetic Resonance |
| NHL | Non-Hodgkin Lymphoma |
| NPs | Nanoparticles |
| PC | Protein Corona |
| PEG | Polyethylene Glycol |
| PET | Positron Emission Tomography |
| PLA | Poly(Lactide) Acid |
| PLC | Poly(ε-Caprolactone) |
| PLGA | Poly(Lactide-co-Glycolide) Acid |
| PMMA | Poly(Methyl Methacrylate) |
| PVA | Polyvinyl Alcohol |
| scFv | Single-Chain Fragment Variable |
| SWCNT | Single-Walled Carbon Nanotube |
| WHO | World Health Organization |